// App-Quantinova.ai

188 : A nurse-led biologic dose tapering programme in patients with rheumatoid arthritis

Researchers

Presenter

  • Marianne Loke

Principal Investigators

  • Ellie Lonsdale

  • Karen Mills

  • Karl Gaffney

Medical Centers

  • Rheumatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved